Interim Acute Toxicity Analysis and Surgical Outcomes of Neoadjuvant Gemcitabine/nab-Paclitaxel and Hypofractionated Image Guided Intensity Modulated Radiation Therapy in Resectable and Borderline Resectable Pancreatic Cancer (ANCHOR) Study.


Journal Article

Full Text

Duke Authors

Cited Authors

  • Palta, M; Czito, B; Abbruzzese, J; Uronis, H; Duffy, EA; Blazer, DT; Willett, CG

Published Date

  • October 1, 2016

Published In

Volume / Issue

  • 96 / 2S

Start / End Page

  • S204 - S205

PubMed ID

  • 27675789

Pubmed Central ID

  • 27675789

Electronic International Standard Serial Number (EISSN)

  • 1879-355X

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2016.06.509


  • ENG

Conference Location

  • United States